Discover
LPCN
Lipocine Inc.
2.46
2 x 1.80
2 x 3.03
bid
ask
-
0.10
3.91%
2 @ 04:00 PM
2.41 -0.05 (2.03%)
| Ytd | -69.36% | |
| 1y | -22.88% |
2.36
day range
2.51
1.81
52 week range
12.37
| Open | 2.50 | Prev Close | 2.56 | Low | 2.36 | High | 2.51 | Mkt Cap | 20.28M |
| Vol | 72.67K | Avg Vol | 398.11K | EPS | -1.96 | P/E | N/A | Forward P/E | -3.87 |
| Beta | 1.19 | Short Ratio | 2.80 | Inst. Own | 9.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 2.30 | 200-d Avg | 4.66 | 1yr Est | 21.50 |
| Income Statement | |||
| Total Revenue | 119.40K | ||
| Revenues (USD) | 119.40K | ||
| Gross Profit | 119.40K | ||
| Operating Expenses | 3.97M | ||
| Research and Development Expense | 2.76M | ||
| Selling, General and Administrative Expense | 1.20M | ||
| Operating Income | -3.85M | ||
| Net Income | -3.67M | ||
| Net Income Common Stock | -3.67M | ||
| Net Income Common Stock (USD) | -3.67M | ||
| Consolidated Income | -3.67M | ||
| Earnings per Basic Share | -0.54 | ||
| Earnings per Basic Share (USD) | -0.54 | ||
| Earnings per Diluted Share | -0.54 | ||
| Earning Before Interest & Taxes (EBIT) | -3.67M | ||
| Earning Before Interest & Taxes (USD) | -3.67M | ||
| Weighted Average Shares | 6.80M | ||
| Weighted Average Shares Diluted | 6.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.02M | ||
| Cash and Equivalents (USD) | 5.02M | ||
| Investments | 19.71M | ||
| Investments Current | 19.71M | ||
| Trade and Non-Trade Receivables | 119.40K | ||
| Current Assets | 25.24M | ||
| Property, Plant & Equipment Net | 89.48K | ||
| Total Assets | 25.36M | ||
| Current Liabilities | 2.53M | ||
| Total Liabilities | 2.53M | ||
| Accumulated Retained Earnings (Deficit) | -213.07M | ||
| Accumulated Other Comprehensive Income | -7.19K | ||
| Shareholders Equity | 22.83M | ||
| Shareholders Equity (USD) | 22.83M | ||
| Assets Non-Current | 113.23K | ||
| Deferred Revenue | 320.00K | ||
| Trade and Non-Trade Payables | 1.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 14.81K | ||
| Net Cash Flow from Financing | 11.97M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -190.23K | ||
| Issuance (Purchase) of Equity Shares | 11.97M | ||
| Net Cash Flow from Investing | -9.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -9.90M | ||
| Net Cash Flow from Operations | -2.26M | ||
| Share Based Compensation | 65.40K | ||